EP3206711
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.10.2015EP published:
31.5.2023EP application number:
15784907.6
EPO information:
European Patent Register
Max expiry date:
12.10.2035
Title in English:
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOFLanguage of the patent:
English
Timeline
Today
13.10.2015EP application
31.5.2023EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, Boston, MA 02215-5450, US
Name:
President and Fellows of Harvard CollegeAddress:
17 Quincy Street, Cambridge, MA 02138, US
Inventor
Name:
FREEMAN, Gordon, JamesAddress:
Brookline, MA 02445, US
Name:
SHARPE, Arlene, HelenAddress:
Brookline, MA 02445, US
Name:
FREY, Gerhard, JohannAddress:
San Diego, CA 92129, US
Name:
CHANG, Hwai, WenAddress:
San Marcos, CA 92069, US
Name:
MATARAZA, Jennifer, MarieAddress:
Cambridgem, MA 02139, US
Name:
DRANOFF, GlennAddress:
Cambridge, MA 02139, US
Priority
Number:
201462063852 PDate:
14.10.2014Country:
US
Number:
201462094847 PDate:
19.12.2014Country:
US
Number:
201562198545 PDate:
29.7.2015Country:
US
Number:
201562213076 PDate:
1.9.2015Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, C07K 16/46, C07K 16/30, A61P 31/00, A61P 35/00, A61P 35/02, A61P 37/02